➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Express Scripts
AstraZeneca
Mallinckrodt
Medtronic

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Promazine hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for promazine hydrochloride and what is the scope of patent protection?

Promazine hydrochloride is the generic ingredient in two branded drugs marketed by Wyeth Ayerst, Watson Labs, and Baxter Hlthcare Corp, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for promazine hydrochloride.

Summary for promazine hydrochloride
Recent Clinical Trials for promazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Richever Enterprise Co., Ltd.Phase 3

See all promazine hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for promazine hydrochloride

US Patents and Regulatory Information for promazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst SPARINE promazine hydrochloride CONCENTRATE;ORAL 010942-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare Corp SPARINE promazine hydrochloride INJECTABLE;INJECTION 010349-006 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PROMAZINE HYDROCHLORIDE promazine hydrochloride INJECTABLE;INJECTION 084510-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst SPARINE promazine hydrochloride TABLET;ORAL 010348-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst SPARINE promazine hydrochloride TABLET;ORAL 010348-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst SPARINE promazine hydrochloride TABLET;ORAL 010348-006 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst SPARINE promazine hydrochloride SYRUP;ORAL 010942-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Express Scripts
AstraZeneca
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.